Loading...
Loading...
Browse all stories on DeepNewz
VisitWhat will be the primary focus of the next major international STI health campaign by end of 2025?
HIV/AIDS • 25%
Genital Herpes • 25%
HPV • 25%
Other • 25%
Announcements from WHO or other international health organizations
Over 846 Million Adults Aged 15-49 Live with Genital Herpes, 42 Million New Cases Annually
Dec 11, 2024, 03:27 AM
A recent survey highlights the widespread prevalence of genital herpes among individuals aged 15 to 49. According to the World Health Organization (WHO), over 846 million adults globally within this age group are living with the infection, which equates to more than one in five people. Additionally, there are 42 million new cases of genital herpes recorded annually. The sexually transmitted infection, which currently has no cure, underscores the need for advancements in vaccine development to address this global health challenge. More than 840 million people under age 50 are affected worldwide.
View original story
Stroke prevention • 25%
Obesity reduction • 25%
Smoking cessation • 25%
Diabetes management • 25%
Malaria prevention • 25%
COVID-19 vaccination • 25%
HIV/AIDS prevention • 25%
Other • 25%
Dietary changes • 25%
Physical activity • 25%
Smoking cessation • 25%
Medication adherence • 25%
PrEP Usage • 25%
Testing and Diagnosis • 25%
Public Awareness Campaigns • 25%
Treatment Programs • 25%
Malaria • 25%
Tuberculosis • 25%
HIV/AIDS • 25%
Tuberculosis eradication • 25%
Malaria eradication • 25%
HIV/AIDS reduction • 25%
Other • 25%
Pandemic Preparedness • 25%
Vaccine Distribution • 25%
Disease Surveillance • 25%
Public Health Education • 25%
Testing and Prevention • 25%
Treatment Access • 25%
Public Awareness Campaigns • 25%
Research and Development • 25%
Economic policies • 25%
Social policies • 25%
Foreign policies • 25%
Other • 25%
Personnel apparatus for policymakers • 25%
Policy development • 25%
Public engagement and outreach • 25%
Discontinued • 25%
Stigma and Discrimination • 25%
Access to Medication • 25%
Lack of Funding • 25%
Ineffective Policies • 25%
Africa • 25%
Asia • 25%
Europe • 25%
Other • 25%
U.S. Presidential Election • 25%
Ukraine War • 25%
European Union Politics • 25%
Other • 25%
Other • 25%
Moderna • 25%
GlaxoSmithKline • 25%
Pfizer • 25%